All Posts By

Smartkarma Daily Briefs

Daily Brief Event-Driven: 7&I (3382 JP) – Alimentation Couche-Tard Walks and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • 7&I (3382 JP) – Alimentation Couche-Tard Walks, Lobbing a Letter Bomb
  • [Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications
  • PointsBet (PBH AU): Betr Firms “Superior Offer”. Expect The Board To Reject. Again
  • Seven & I Holdings (3382 JP): Dead Money as Couche-Tard Unsurprisingly Walks
  • Samsung Jay Lee Cleared by Supreme Court — Market Reaction Could Flip From Consensus
  • A Merger Between Hanil Cement and Hanil Hyundai Cement to Become the #1 Cement Player in Korea
  • Insiders Selling at Silicon2: Negative Impact on Share Price


7&I (3382 JP) – Alimentation Couche-Tard Walks, Lobbing a Letter Bomb

By Travis Lundy

  • Alimentation Couche-Tard (ATD CN) which proposed a takeover to Seven & I Holdings (3382 JP) almost a year ago, has walked. They delivered a letter bomb on the way out.
  • The letter is titled “ALIMENTATION COUCHE-TARD ANNOUNCES WITHDRAWAL OF PROPOSAL TO ACQUIRE SEVEN & I HOLDINGS DUE TO LACK OF ENGAGEMENT.” This is not the first time they have complained.
  • The letter is not aimed at the 7&i Board or at ATD stakeholders. It is meant to drive a wedge between 7&i active shareholders and its management team. We’ll see.

[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications

By Travis Lundy

  • Today, Mitsui Matsushima (1518 JP) announced the results of its Buyback Tender Offer to repurchase up to 3,999,999 shares (35.8% of shares out ex-Treasury) at ¥5,000/share. 
  • Murakami-San owned 42% of the voting rights at announcement, then bought more on the dip just below ¥5,000/share. 
  • The Tender Offer Buyback was “successful” in that it bought back 3.3mm shares. But the result was FAR more interesting than I expected. Surprising Results with Surprising Implications

PointsBet (PBH AU): Betr Firms “Superior Offer”. Expect The Board To Reject. Again

By David Blennerhassett

  • Back on the 20th June, betr (BBT AU) tabled an all-scrip off-market Offer for PointsBet (PBH AU), with no minimum acceptance condition, which they considered superior to MIXI (2121 JP)‘s.
  • Which was a bold statement, as 3.81 new betr shares, at the time, was equivalent to A$1.143/share versus MIXI’s A$1.20/share all-cash Offer. It’s now worth A$1.03/share. 
  • Last night, betr released its Bidder’s Statement. Terms are unchanged.  Offer opens ~31st July. PointsBet was quick to point out, again, the current (low) value of the scrip terms.

Seven & I Holdings (3382 JP): Dead Money as Couche-Tard Unsurprisingly Walks

By Arun George

  • Couche-Tard has withdrawn its offer for Seven & I Holdings (3382 JP) by unfairly laying the entire blame on the Board.
  • The Board has made credible progress, but the jury is still out on whether the Board’s plan will generate returns. Shareholders remain sceptical as the shares have underperformed the index.
  • In theory, the sell-off presents a buying opportunity (My SoTP valuation is JPY 2,376). However, the shares are likely to tread water as there are no near-term catalysts. 

Samsung Jay Lee Cleared by Supreme Court — Market Reaction Could Flip From Consensus

By Sanghyun Park

  • Jay Lee’s clean Supreme Court win may cool Samsung’s governance trade near term. With legal risks gone, there’s less urgency to push structural changes or shuffle shares now.
  • Samsung C&T, a hotspot for governance spec flows, may see bids fade as urgency for structural shifts drops; longs on revamp bets might consider fading or shorting amid lingering risks.
  • Samsung Life gets relief as forced Elec share sales drop, supporting its stock. Samsung Elec stays neutral. Trade idea: Samsung Life long, Samsung C&T short on cooled governance hopes.

A Merger Between Hanil Cement and Hanil Hyundai Cement to Become the #1 Cement Player in Korea

By Douglas Kim

  • After the market close today (17 July), Hanil Cement Co Ltd/New (300720 KS) and Hanil Hyundai Cement (006390 KS) announced that they will merge.
  • Through this merger, Hanil Cement (on a combined basis with pro-forma sales of 1.74 trillion won in 2024) will become the largest cement company in Korea after Ssangyong Cement Industrial.
  • We expect this merger to have a positive impact on both companies and they are likely to outperform the market and other local cement producers this year. 

Insiders Selling at Silicon2: Negative Impact on Share Price

By Douglas Kim

  • Insiders have been selling at Silicon2 (257720 KS). The company’s CEO Kim Seong-Woon and other related parties sold 0.37 million shares (0.6% stake) in June 2025.
  • Overall, we are concerned about this recent insider selling at Silicon2. We are lowering our rating on Silicon2 to Negative over the next 6-12 months. 
  • Silicon2 needs to introduce new cosmetic brands such as Joseon Beauty, Round Lab, and Anua that could become very popular on a regular basis. However, that could be a challenge. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: TSMC 2Q25: A Number of Very Positive Messages and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue
  • TSMC 2Q25 Takeways: Undervalued Op Leverage and Capacity Strain Setting Up 2026 N2 Growth Suprise
  • TSMC (2330.TT; TSM.US): FX Could Make an Impact; Full Year USD Revenue Raised to ~30% YoY.
  • Geely (175 HK): Deliveries Up by 42% YoY in June – Rapid Growth to Go On in 3Q25
  • Square Enix (9684) | Turnaround in Motion
  • Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!
  • Insignia Financial Ltd – The Overnight Report: New ASX Record Beckons
  • Computershare Limited: Initiation of Coverage- How Smart Hedging & Rate Moves Are Driving a $1.8 Billion Windfall!
  • Max Healthcare (MAXHEALT IN): Sell
  • NEXTDC Ltd – Rudi’s View: Aussie Broadband, oOh!media, Paladin Energy, Seek, Xero & More


TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue

By Nicolas Baratte

  • NT$ appreciation large impact on revenue / margins but TSMC beats consensus in 2Q, 3Q guidance is in-line. FX impact is partially neutralize by other factors (utilization, cost control) .
  • This will be controversial: management increase 2025 US$-revenue growth from mid-20 to 30%. Yet, this implies that 4Q25 US$-revenue growth will collapse to 9% YoY and NT$-growth will be negative.
  • At same time, mngt gives a long list of very positive messages on AI demand, N2 ramp, full utilization of EUV nodes.  This could lead to short-term stock price weakness.

TSMC 2Q25 Takeways: Undervalued Op Leverage and Capacity Strain Setting Up 2026 N2 Growth Suprise

By Vincent Fernando, CFA

  • TSMC Beats, Raises, and Confirms AI Ramp Is Real, Despite FX Drag
  • Conclusion — Maintain Structural Long View, 2026 Growth Likely Underappreciated
  • TSMC ADR Premium Rebounds to 23.6% — US Investor Positioning Skewed Toward TSMC’s Unique AI Exposure

TSMC (2330.TT; TSM.US): FX Could Make an Impact; Full Year USD Revenue Raised to ~30% YoY.

By Patrick Liao

  • 3Q25 Guidance: Revenue: US$31.8–33.0 billion (approx. 8% QoQ growth); Gross Margin: 55.5–57.5%; Operating Margin: 45.5–47.5%.
  • Despite FX headwinds, TSMC aims to maintain gross margin ≥ 53%  
  • Driven by strong demand in AI (including sovereign AI) and HPC; Full-year USD revenue growth outlook raised to ~30% YoY.

Geely (175 HK): Deliveries Up by 42% YoY in June – Rapid Growth to Go On in 3Q25

By Ming Lu

  • Geely announced that its deliveries grew by 42% YoY in June 2025.
  • We expect BEV deliveries will continue to grow fast in 3Q25, but slow down from 4Q25.
  • We believe the stock price will rise by 39% for the next twelve months.

Square Enix (9684) | Turnaround in Motion

By Mark Chadwick

  • Square Enix holds globally recognized IP with monetization upside across platforms, and recent pipeline discipline signals a shift toward higher-margin, high-quality titles that can stabilize earnings and restore growth.
  • Activist involvement is intensifying, creating strong pressure for capital returns, governance reform, and strategic clarity – unlocking shareholder value in a business that remains structurally underleveraged and undervalued vs peers.
  • With operating margins improving, digital sales accelerating, and cost structures being realigned, Square Enix is positioned to re-rate meaningfully as investor confidence rebuilds and management delivers on core turnaround objectives.

Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!

By Baptista Research

  • The tragic crash of Air India Flight 171, a Boeing 787-8 Dreamliner, on June 12, 2025, initially triggered global alarm over the safety of Boeing’s aircraft, evoking chilling memories of the 737 MAX debacle.
  • However, a preliminary report by India’s Aircraft Accident Investigation Bureau (AAIB) appears to shift attention away from mechanical failure and toward pilot actions.
  • According to the report, both fuel control switches were inexplicably moved from the “RUN” to the “CUTOFF” position seconds after takeoff—starving both engines of fuel.


Computershare Limited: Initiation of Coverage- How Smart Hedging & Rate Moves Are Driving a $1.8 Billion Windfall!

By Baptista Research

  • Computershare presented a robust performance in its first-half FY ’25 results.
  • The company reported Management Earnings Per Share (EPS) of $0.653, an 18.7% increase over the previous period, driven by strong business momentum despite challenging macroeconomic conditions, including interest rate changes.
  • The company’s management aims to build a simplified, high-quality, and capital-light business model, as evidenced by their recent divestment of the U.S. Mortgage Services business.

Max Healthcare (MAXHEALT IN): Sell

By Avien Pillay

  • We are bullish on the long-term growth of the hospital sector in India.
  • Like in the case of Apollo Hospitals, Max Healthcare will have tough competition from both listed and unlisted players.
  • A 65 FPE does not factor in the high cost of expansion and potential challenges.

NEXTDC Ltd – Rudi’s View: Aussie Broadband, oOh!media, Paladin Energy, Seek, Xero & More

By FNArena

  • Update on changes to and revisions of analysts’ Best Ideas and Conviction Calls, as well as Model Portfolio compositions

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Lucror Analytics – Morning Views Asia and more

By | Credit, Daily Briefs

In today’s briefing:

  • Lucror Analytics – Morning Views Asia


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Adani Ports
  • Front-end UST yields declined yesterday, on account of subdued PPI data. The curve steepened meaningfully, following reports that US President Donald Trump had discussed with Republican members of Congress the dismissal of Fed Chairman Jerome Powell (which Mr Trump subsequently denied).
  • The yield on the 2Y UST fell 5 bps to 3.89%, while the yield on the 10Y UST was down 3 bps at 4.46%. Equities recovered from an earlier sell-off, with the S&P 500 and Nasdaq both ending 0.3% higher at 6,264 and 20,730, respectively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Crypto: Altcoin Strategic Reserves: Why Are Public Companies Buying Altcoins? and more

By | Crypto, Daily Briefs

In today’s briefing:

  • Altcoin Strategic Reserves: Why Are Public Companies Buying Altcoins?


Altcoin Strategic Reserves: Why Are Public Companies Buying Altcoins?

By Animoca Brands Research

  • Evolving Treasury Landscape: Corporate treasuries face challenges from macroeconomic shifts, including high interest rate volatility, significant monetary expansion leading to inflation, and increasing geopolitical risks impacting cash flows and profitability.
  • Bitcoin as a Strategic Asset: Bitcoin has emerged as an alternative asset for these challenges, offering a scarce and increasingly institutionally viable asset for potential long-term value preservation and portfolio diversification, as demonstrated by MicroStrategy’s pioneering strategy.
  • The “Financial Engineering” Playbook: MicroStrategy’s approach goes beyond simple asset allocation, employing sophisticated financial engineering (e.g., convertible notes, equity issuances) to create value for shareholders by continuously acquiring more Bitcoin per share. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: UK Jobs Data And The Muddled MPC and more

By | Daily Briefs, Macro

In today’s briefing:

  • UK Jobs Data And The Muddled MPC
  • Will Gold Stocks Protect You in a Crisis? (Dirk Baur)
  • CX Daily: India’s Sputtering Efforts to Boost Manufacturing Investment
  • Hybridan Small Cap Feast: 09/07/2025
  • Actinver Research – Mexico Equity Research: 2Q25 Preview


UK Jobs Data And The Muddled MPC

By Phil Rush

  • UK payroll revisions removed most of May’s weakness, while wage and price inflation is too fast, yet the BoE probably won’t back down from an August cut as the UR rises.
  • Fewer payroll inflows explain its downtrend, with <24yo suffering sustained pain, but the 25-64yo endure the taxation hit, structurally raising unemployment by ~0.5pp.
  • Wage growth isn’t showing signs of new disinflationary demand pressures, so we expect excessive underlying wage and price trends to persist, not helped by an August BoE cut.

Will Gold Stocks Protect You in a Crisis? (Dirk Baur)

By Money of Mine

  • Discussing research on gold and related metals with Dr. Dirk Bauer
  • Examining the valuation of gold compared to other asset classes
  • Differentiating between gold’s role as a hedge and a safe haven in times of financial turmoil

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


CX Daily: India’s Sputtering Efforts to Boost Manufacturing Investment

By Caixin Global

  • India / In Depth: India’s sputtering efforts to boost manufacturing investment
  • Jobs /: More young Chinese are giving up on the job hunt, study says
  • Batteries /: China tightens export rules to protect its lead in lithium battery tech

Hybridan Small Cap Feast: 09/07/2025

By Hybridan

  • 80 Mile 0.24p £9.45m (80M.L) The exploration and development Company updates on its interest in Greenswitch Srl and Hydrogen Valley.
  • Greenswitch has signed a Memorandum of Understanding to sell up to 40,000 tonnes per year of biofuel to Tecnoparco to use in cogeneration units.
  • This shortens the supply chain and helps to increase sustainability by moving away from palm oil. 

Actinver Research – Mexico Equity Research: 2Q25 Preview

By Actinver

  • Another quarter with soft conditions; a slowdown across most industries is expected, along with FX-related effects in some companies and weather headwinds for some others.
  • Similar to previous quarters, we forecast on average margin contraction for our covered companies, as companies struggle with a weaker operating leverage (among other factors).
  • In Consumer, we are mostly lowering our PTs, while upgrading Gruma to Market Perform (from Underperform). Overall, FX remains a key factor, albeit at a lower scale vs previously expected.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Mitsui Matsushima, Boeing Co, Safex Chemicals (India) Limited, Inpost, Adani Ports & Special Economic Zone, Randstad Holding Nv, IMCD Group NV and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications
  • Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!
  • Safex Chemicals India Ltd Pre-IPO Tearsheet
  • InPost: Initiation of Coverage- How E-Commerce & AI Magic Can Fuel Its Future Growth!
  • Lucror Analytics – Morning Views Asia
  • Randstad: Initiation of Coverage- Can Diversification & Digital Muscle Future-Proof This Staffing Titan?
  • IMCD: Initiation of Coverage- Is The Strong Organic Growth in Americas Region Here To Stay?


[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications

By Travis Lundy

  • Today, Mitsui Matsushima (1518 JP) announced the results of its Buyback Tender Offer to repurchase up to 3,999,999 shares (35.8% of shares out ex-Treasury) at ¥5,000/share. 
  • Murakami-San owned 42% of the voting rights at announcement, then bought more on the dip just below ¥5,000/share. 
  • The Tender Offer Buyback was “successful” in that it bought back 3.3mm shares. But the result was FAR more interesting than I expected. Surprising Results with Surprising Implications

Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!

By Baptista Research

  • The tragic crash of Air India Flight 171, a Boeing 787-8 Dreamliner, on June 12, 2025, initially triggered global alarm over the safety of Boeing’s aircraft, evoking chilling memories of the 737 MAX debacle.
  • However, a preliminary report by India’s Aircraft Accident Investigation Bureau (AAIB) appears to shift attention away from mechanical failure and toward pilot actions.
  • According to the report, both fuel control switches were inexplicably moved from the “RUN” to the “CUTOFF” position seconds after takeoff—starving both engines of fuel.

Safex Chemicals India Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Safex Chemicals (India) Limited (1414700D IN)  (SCIL)  is looking to raise about US$100m in its upcoming India IPO. The bookrunners for the deal are Axis, JM Fin, SBI.
  • SCIL is a specialty chemicals company in agrochemicals, operating across branded formulation, specialty chemicals, and CDMO segments, serving both farmers and global agrochemical firms.
  • According to the Frost & Sullivan Report, SCIL  was among the fastest-growing players in the Indian agrochemical industry in terms of revenue growth between FY2023-25.

InPost: Initiation of Coverage- How E-Commerce & AI Magic Can Fuel Its Future Growth!

By Baptista Research

  • InPost reported its Q1 2025 financial results, showcasing a promising start to the year, but with challenges and opportunities navigating its multiple international markets.
  • The company experienced robust year-on-year revenue growth of 22%, and a 29% increase when excluding currency effects.
  • The group adjusted EBITDA rose by 24%, indicating improved profitability across all segments.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Adani Ports
  • Front-end UST yields declined yesterday, on account of subdued PPI data. The curve steepened meaningfully, following reports that US President Donald Trump had discussed with Republican members of Congress the dismissal of Fed Chairman Jerome Powell (which Mr Trump subsequently denied).
  • The yield on the 2Y UST fell 5 bps to 3.89%, while the yield on the 10Y UST was down 3 bps at 4.46%. Equities recovered from an earlier sell-off, with the S&P 500 and Nasdaq both ending 0.3% higher at 6,264 and 20,730, respectively.

Randstad: Initiation of Coverage- Can Diversification & Digital Muscle Future-Proof This Staffing Titan?

By Baptista Research

  • Randstad’s first-quarter 2025 financial performance showcased a mix of resilience and ongoing challenges amid a volatile market landscape.
  • Alexander van’t Noordende, the CEO, lauded a robust start to the year, underscoring strategic maneuvering, enhanced commercial efforts, and focused cost management.
  • Their efforts helped sustain bottom-line figures, resulting in an EBITA of EUR 167 million with a 3% EBITA margin.

IMCD: Initiation of Coverage- Is The Strong Organic Growth in Americas Region Here To Stay?

By Baptista Research

  • IMCD N.V., a leading distributor in the specialty chemicals and food ingredients sectors, delivered a mixed but largely positive financial performance in the first quarter of 2025, despite ongoing global economic uncertainties.
  • With Marcus Jordan stepping up as CEO following Valerie Diele-Braun’s resignation for personal reasons, the leadership transition marks a critical juncture for the company.
  • The company’s financial results indicate solid growth marked by a 10% increase in gross profit to EUR 325 million and a 12% rise in EBITA to EUR 142 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief TMT/Internet: Taiwan Semiconductor (TSMC), Taiwan Semiconductor (TSMC) – ADR, CoreWeave, Square Enix Holdings, Netdragon Websoft, Nextdc Ltd, Computershare Ltd, SureCore, BE Semiconductor Industries NV and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue
  • TSMC 2Q25 Takeways: Undervalued Op Leverage and Capacity Strain Setting Up 2026 N2 Growth Suprise
  • TSMC (2330.TT; TSM.US): FX Could Make an Impact; Full Year USD Revenue Raised to ~30% YoY.
  • CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition
  • Square Enix (9684) | Turnaround in Motion
  • Quiddity Leaderboard HSIII Sep25: Three Changes Likely; US$364mn One-Way Flows
  • NEXTDC Ltd – Rudi’s View: Aussie Broadband, oOh!media, Paladin Energy, Seek, Xero & More
  • Computershare Limited: Initiation of Coverage- How Smart Hedging & Rate Moves Are Driving a $1.8 Billion Windfall!
  • Podcast EP297: An Overview of sureCore’s New Silicon Services with Paul Wells
  • BE Semiconductor – Why Hybrid Bonding Could Be Its Billion-Dollar Breakthrough!


TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue

By Nicolas Baratte

  • NT$ appreciation large impact on revenue / margins but TSMC beats consensus in 2Q, 3Q guidance is in-line. FX impact is partially neutralize by other factors (utilization, cost control) .
  • This will be controversial: management increase 2025 US$-revenue growth from mid-20 to 30%. Yet, this implies that 4Q25 US$-revenue growth will collapse to 9% YoY and NT$-growth will be negative.
  • At same time, mngt gives a long list of very positive messages on AI demand, N2 ramp, full utilization of EUV nodes.  This could lead to short-term stock price weakness.

TSMC 2Q25 Takeways: Undervalued Op Leverage and Capacity Strain Setting Up 2026 N2 Growth Suprise

By Vincent Fernando, CFA

  • TSMC Beats, Raises, and Confirms AI Ramp Is Real, Despite FX Drag
  • Conclusion — Maintain Structural Long View, 2026 Growth Likely Underappreciated
  • TSMC ADR Premium Rebounds to 23.6% — US Investor Positioning Skewed Toward TSMC’s Unique AI Exposure

TSMC (2330.TT; TSM.US): FX Could Make an Impact; Full Year USD Revenue Raised to ~30% YoY.

By Patrick Liao

  • 3Q25 Guidance: Revenue: US$31.8–33.0 billion (approx. 8% QoQ growth); Gross Margin: 55.5–57.5%; Operating Margin: 45.5–47.5%.
  • Despite FX headwinds, TSMC aims to maintain gross margin ≥ 53%  
  • Driven by strong demand in AI (including sovereign AI) and HPC; Full-year USD revenue growth outlook raised to ~30% YoY.

CoreWeave (CRWV US): Forecasted Addition to Nasdaq100 Replacing Ansys Post-Acquisition

By Dimitris Ioannidis

  • The acquisition of Ansys Inc (ANSS US) by Synopsys Inc (SNPS US) has been completed today, 17 July and Ansys is expected to be deleted from Nasdaq100.
  • CoreWeave (CRWV US) is forecasted to be added to Nasdaq100 as the replacement because it is the highest ranked eligible non-constituent following its recent listing on 28 March 2025.
  • Top addition candidate for the December 2025 annual review is now Kimberly Clark (KMB US) following its listing transfer from NYSE to Nasdaq on 30 May 2025.

Square Enix (9684) | Turnaround in Motion

By Mark Chadwick

  • Square Enix holds globally recognized IP with monetization upside across platforms, and recent pipeline discipline signals a shift toward higher-margin, high-quality titles that can stabilize earnings and restore growth.
  • Activist involvement is intensifying, creating strong pressure for capital returns, governance reform, and strategic clarity – unlocking shareholder value in a business that remains structurally underleveraged and undervalued vs peers.
  • With operating margins improving, digital sales accelerating, and cost structures being realigned, Square Enix is positioned to re-rate meaningfully as investor confidence rebuilds and management delivers on core turnaround objectives.

Quiddity Leaderboard HSIII Sep25: Three Changes Likely; US$364mn One-Way Flows

By Janaghan Jeyakumar, CFA

  • The Hang Seng Internet & IT (HSIII) index represents the top 30 stocks related to internet and information technology businesses listed in Hong Kong (HKEX).
  • In this insight, we take a look at the final rankings of potential ADDs and potential DELs for the September 2025 index rebal event.
  • We see three ADDs/DELs and one float percentage revision which could collectively trigger roughly US$364mn in one-way index flows in September 2025.

NEXTDC Ltd – Rudi’s View: Aussie Broadband, oOh!media, Paladin Energy, Seek, Xero & More

By FNArena

  • Update on changes to and revisions of analysts’ Best Ideas and Conviction Calls, as well as Model Portfolio compositions

Computershare Limited: Initiation of Coverage- How Smart Hedging & Rate Moves Are Driving a $1.8 Billion Windfall!

By Baptista Research

  • Computershare presented a robust performance in its first-half FY ’25 results.
  • The company reported Management Earnings Per Share (EPS) of $0.653, an 18.7% increase over the previous period, driven by strong business momentum despite challenging macroeconomic conditions, including interest rate changes.
  • The company’s management aims to build a simplified, high-quality, and capital-light business model, as evidenced by their recent divestment of the U.S. Mortgage Services business.

Podcast EP297: An Overview of sureCore’s New Silicon Services with Paul Wells

By SemiWiki.com

  • Surecore offers a one-stop shop for SoC and IP design, from architecture to test, chip evaluation, and more
  • Surecore’s team of highly experienced memory and mixed signal designers differentiate them from other design services providers
  • Surecore’s expertise in low power design helps customers overcome challenges in advanced nodes, such as leakage and thermal management, ensuring sustainable next generation silicon solutions

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


BE Semiconductor – Why Hybrid Bonding Could Be Its Billion-Dollar Breakthrough!

By Baptista Research

  • BE Semiconductor Industries N.V. (Besi) recently reported its first quarter 2025 results, underlining a mixed performance amidst a challenging market environment.
  • The company achieved revenues of €144.1 million, marking a slight decline of 1.5% compared to the same quarter last year.
  • This reduction reflects continued weaknesses in the mobile and automotive markets, although there was some compensation from a surge in demand related to hybrid bonding and AI-related computing applications.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: Gold, Hanil Cement Co Ltd/New, KEFI Minerals PLC, Pharos Energy, Asian Paints, Warriedar Resources and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • Will Gold Stocks Protect You in a Crisis? (Dirk Baur)
  • A Merger Between Hanil Cement and Hanil Hyundai Cement to Become the #1 Cement Player in Korea
  • KEFI Gold and Copper — Code word imminent
  • Pharos Energy Plc (LSE: PHAR): Operations on track. Six well drilling programme to commence in Vietnam in 3Q25
  • Asian Paints Vs. Grasim: The Anti-Trust Showdown
  • Warriedar Resources Ltd – Quarterly Round Up


Will Gold Stocks Protect You in a Crisis? (Dirk Baur)

By Money of Mine

  • Discussing research on gold and related metals with Dr. Dirk Bauer
  • Examining the valuation of gold compared to other asset classes
  • Differentiating between gold’s role as a hedge and a safe haven in times of financial turmoil

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


A Merger Between Hanil Cement and Hanil Hyundai Cement to Become the #1 Cement Player in Korea

By Douglas Kim

  • After the market close today (17 July), Hanil Cement Co Ltd/New (300720 KS) and Hanil Hyundai Cement (006390 KS) announced that they will merge.
  • Through this merger, Hanil Cement (on a combined basis with pro-forma sales of 1.74 trillion won in 2024) will become the largest cement company in Korea after Ssangyong Cement Industrial.
  • We expect this merger to have a positive impact on both companies and they are likely to outperform the market and other local cement producers this year. 

KEFI Gold and Copper — Code word imminent

By Edison Investment Research

Since our last note at the end of March, KEFI has appointed BCM as its preferred mining contractor and raised £7.6m in equity (supported by Konwave, Phoenix, Premier Miton, RAB and Ruffer, among others) to expedite the launch of the Tulu Kapi project. On site, it has constructed a new access road, a temporary construction camp, security camps and logistics control rooms, as well as drilling water boreholes and completing contractors’ certifiers’ inspections. New host lands have been allocated for all local residents requiring resettlement, and property surveys for compensation for Phase 1 resettlement, for a temporary construction camp, security camps and for a new access road have all been completed. This week, it announced the triggering of compensation payments to the resettling community. As a result, its US$320m financing package is now entering its final stages, with independent certifications targeted for completion this month and definitive agreements next month, followed by drawdown and mobilisation shortly thereafter. With contractual finalisation imminent, KEFI’s shares are at a key inflection point, with the company now targeting first gold in late FY27.


Pharos Energy Plc (LSE: PHAR): Operations on track. Six well drilling programme to commence in Vietnam in 3Q25

By Auctus Advisors

  • 1H25 production was 5,642 boe/d, broadly in line with our expectations of ~5,800 boe/d.
  • This also compares well with production of 5,757 boe/d from January to April.
  • Production in Vietnam remained stable at 4,183 boe/d in 1H25, compared to 4,216 boe/d over the January–April period.

Asian Paints Vs. Grasim: The Anti-Trust Showdown

By Sudarshan Bhandari

  • Grasim (Birla Opus) filed an antitrust complaint alleging Asian Paints used dealer-exclusivity, supply-chain pressure, and reputational tactics to throttle its rollout.
  • CCI’s prima-facie order opens a DG probe; outcome could reset the playbook on dealer contracts in all B2C staples. 
  • DG has 90 days to file its report. Possible end-states: (i) dismissal, (ii) monetary penalty + conduct remedies (exclusivity clauses void), (iii) structural remedy (unlikely).

Warriedar Resources Ltd – Quarterly Round Up

By Research as a Service (RaaS)

  • Warriedar Resources Limited (ASX:WA8) is an emerging gold and antimony developer whose flagship Golden Range project hosts ~2.3moz in AuEq resources in the prolific gold-producing Murchison region of Western Australia.
  • Since the acquisition of the project in CY23, WA8 has expanded the gold resource and delineated a globally significant antimony resource which is also contained in the core Ricciardo deposit.
  • Whilst the gold resource alone could support a commercial development, the overlapping antimony resource not only increases the economic value, it adds a strategic value to the project given the supply shortages and trade restrictions affecting this commodity.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Consun Pharmaceutical, Nanjing Leads Biolabs, The United Laboratories International Holdings Limited, Max Healthcare Institute, Ascentage Pharma Group Corp, Waters Corp, Orasure Technologies, Shofu Inc, NanoViricides and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Quiddity Leaderboard Hang Seng Biotech Sep25: 20 Deletions Likely Due to Major Methodology Change
  • Leads Biolabs (维立志生物) IPO: A Duality Repeat?
  • United Lab Placement – Industry Momentum Strong, Although Stock Has Run-Up Quite a Bit
  • Max Healthcare (MAXHEALT IN): Sell
  • Ascentage Pharma (6855 HK): Placement Priced Reasonably; Pipeline Leads to Niche Market Opportunity
  • Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!
  • Nanjing Leads Biolabs IPO: Lead Asset Targets Niche Market; Path to Success Still Long
  • OraSure Rebuffs Ron Zwanziger’s Buyout Bid—Will He Try Again?
  • Shofu Inc (7979 JP): Coverage Initiation
  • NanoViricides Inc –


Quiddity Leaderboard Hang Seng Biotech Sep25: 20 Deletions Likely Due to Major Methodology Change

By Janaghan Jeyakumar, CFA

  • The Hang Seng Biotech Index (HSHKBIO) will represent the 30 largest biotech companies listed in Hong Kong (HKEX) from September 2025.
  • Due to a methodology change for HSHKBIO announced in late-June 2025, 20 index constituents could face deletion in September 2025.
  • In this insight, we take a look at our final expectations for index changes and capping flows for HSHKBIO index rebal event in September 2025.

Leads Biolabs (维立志生物) IPO: A Duality Repeat?

By Ke Yan, CFA, FRM

  • Leads Biolabs, a China-based clinical-stage biotechnology company, launched its IPO to raise up to US$144m via a Hong Kong listing.
  • We look at the deal dynamics and compare the listing with the Duality listing.
  • The deal values the companies fairly but we see strong sentiment towards quality biotech names.

United Lab Placement – Industry Momentum Strong, Although Stock Has Run-Up Quite a Bit

By Akshat Shah

  • The United Laboratories International Holdings Limited (3933 HK) is looking to raise up to US$262m from a primary placement. 
  • The company intends to use about 60% of the proceeds to build production capacity and expand its international business, with the rest to be used for R&D purposes.
  • In this note, we will talk about the placement and run the deal through our ECM framework.

Max Healthcare (MAXHEALT IN): Sell

By Avien Pillay

  • We are bullish on the long-term growth of the hospital sector in India.
  • Like in the case of Apollo Hospitals, Max Healthcare will have tough competition from both listed and unlisted players.
  • A 65 FPE does not factor in the high cost of expansion and potential challenges.

Ascentage Pharma (6855 HK): Placement Priced Reasonably; Pipeline Leads to Niche Market Opportunity

By Tina Banerjee

  • Ascentage Pharma Group Corp (6855 HK) announced the placement of 22M shares for subscription at HK$68.6 per share, representing 8% discount to last trading price before announcement.
  • The company intends to use the net proceeds for commercialization efforts, global clinical development to advance the core pipeline candidates and for infrastructure and working capital to strengthen global operations.
  • The launch of lisaftoclax in China followed by eventual approval olverembatinib in US would be the near-term triggers for the company.

Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!

By Baptista Research

  • Waters Corporation has officially entered a new phase of its growth journey with the $17.5 billion acquisition of Becton Dickinson’s biosciences and diagnostic-solutions business.
  • The deal, announced in July 2025, is structured as a merger but effectively represents a strategic divestiture by Becton Dickinson, which has opted to focus more intensively on its core medtech operations.
  • Waters, best known for its laboratory instrumentation and software, will issue 39% of its shares to BD shareholders and assume $4 billion in debt.

Nanjing Leads Biolabs IPO: Lead Asset Targets Niche Market; Path to Success Still Long

By Tina Banerjee

  • Nanjing Leads Biolabs has launched HK$1.1B IPO to fund its ongoing and planned clinical development and regulatory affairs of pipeline assets. The company has fetched cornerstone investment of ~HK$ 542M.
  • Lead product candidate, LBL-024 is being evaluated for extra-pulmonary neuroendocrine carcinoma. Leads Biolabs expects to file the first BLA for LBL-024 by 3Q26 and anticipate obtaining conditional approval by 2Q27.
  • Positive investor sentiment toward Chinese biotech companies and near-term catalyst being Phase 3 data readout for LBL-024 in early 2026 are the main reasons to subscribe.

OraSure Rebuffs Ron Zwanziger’s Buyout Bid—Will He Try Again?

By Baptista Research

  • OraSure Technologies, Inc. outlined its financial results for the first quarter of 2025, revealing a nuanced performance in the face of ongoing industry challenges.
  • The quarter saw the company reporting total revenues of $29.9 million, with core revenue—which excludes COVID-19 products and exited businesses—at $29.5 million.
  • Although this reflects a slight 2% decrease from the previous year, it marks stability after adjusting for prior business divestitures.

Shofu Inc (7979 JP): Coverage Initiation

By Shared Research

  • In FY03/25, the company reported revenue of JPY38.7bn (+10.3% YoY), operating profit of JPY5.4bn (+14.5% YoY), recurring profit of JPY5.5bn (+7.9% YoY), and net income attributable to owners of the parent of JPY4.6bn (+18.1% YoY).
  • Domestic revenue rose 7.5% YoY to JPY16.0bn, while overseas revenue increased 12.4% YoY to JPY22.7bn.
  • The overseas revenue growth was driven by sales expansion in China and other Asian markets (excluding forex impact, overseas revenue grew 7.1%).

NanoViricides Inc –

By Zacks Small Cap Research

  • Zacks Small-Cap Research Note for NanoViricides, Inc. (NNVC)

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Mitsui Matsushima, Boeing Co, Safex Chemicals (India) Limited, Inpost, Adani Ports & Special Economic Zone, Randstad Holding Nv, IMCD Group NV and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications
  • Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!
  • Safex Chemicals India Ltd Pre-IPO Tearsheet
  • InPost: Initiation of Coverage- How E-Commerce & AI Magic Can Fuel Its Future Growth!
  • Lucror Analytics – Morning Views Asia
  • Randstad: Initiation of Coverage- Can Diversification & Digital Muscle Future-Proof This Staffing Titan?
  • IMCD: Initiation of Coverage- Is The Strong Organic Growth in Americas Region Here To Stay?


[Japan Activism] Mitsui Matsushima (1518 JP) Buyback Tender – Surprising Results and Implications

By Travis Lundy

  • Today, Mitsui Matsushima (1518 JP) announced the results of its Buyback Tender Offer to repurchase up to 3,999,999 shares (35.8% of shares out ex-Treasury) at ¥5,000/share. 
  • Murakami-San owned 42% of the voting rights at announcement, then bought more on the dip just below ¥5,000/share. 
  • The Tender Offer Buyback was “successful” in that it bought back 3.3mm shares. But the result was FAR more interesting than I expected. Surprising Results with Surprising Implications

Boeing Breathes Easy For Now, But AI171 Crash Leaves A Trail Of Uncomfortable Questions!

By Baptista Research

  • The tragic crash of Air India Flight 171, a Boeing 787-8 Dreamliner, on June 12, 2025, initially triggered global alarm over the safety of Boeing’s aircraft, evoking chilling memories of the 737 MAX debacle.
  • However, a preliminary report by India’s Aircraft Accident Investigation Bureau (AAIB) appears to shift attention away from mechanical failure and toward pilot actions.
  • According to the report, both fuel control switches were inexplicably moved from the “RUN” to the “CUTOFF” position seconds after takeoff—starving both engines of fuel.

Safex Chemicals India Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Safex Chemicals (India) Limited (1414700D IN)  (SCIL)  is looking to raise about US$100m in its upcoming India IPO. The bookrunners for the deal are Axis, JM Fin, SBI.
  • SCIL is a specialty chemicals company in agrochemicals, operating across branded formulation, specialty chemicals, and CDMO segments, serving both farmers and global agrochemical firms.
  • According to the Frost & Sullivan Report, SCIL  was among the fastest-growing players in the Indian agrochemical industry in terms of revenue growth between FY2023-25.

InPost: Initiation of Coverage- How E-Commerce & AI Magic Can Fuel Its Future Growth!

By Baptista Research

  • InPost reported its Q1 2025 financial results, showcasing a promising start to the year, but with challenges and opportunities navigating its multiple international markets.
  • The company experienced robust year-on-year revenue growth of 22%, and a 29% increase when excluding currency effects.
  • The group adjusted EBITDA rose by 24%, indicating improved profitability across all segments.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Adani Ports
  • Front-end UST yields declined yesterday, on account of subdued PPI data. The curve steepened meaningfully, following reports that US President Donald Trump had discussed with Republican members of Congress the dismissal of Fed Chairman Jerome Powell (which Mr Trump subsequently denied).
  • The yield on the 2Y UST fell 5 bps to 3.89%, while the yield on the 10Y UST was down 3 bps at 4.46%. Equities recovered from an earlier sell-off, with the S&P 500 and Nasdaq both ending 0.3% higher at 6,264 and 20,730, respectively.

Randstad: Initiation of Coverage- Can Diversification & Digital Muscle Future-Proof This Staffing Titan?

By Baptista Research

  • Randstad’s first-quarter 2025 financial performance showcased a mix of resilience and ongoing challenges amid a volatile market landscape.
  • Alexander van’t Noordende, the CEO, lauded a robust start to the year, underscoring strategic maneuvering, enhanced commercial efforts, and focused cost management.
  • Their efforts helped sustain bottom-line figures, resulting in an EBITA of EUR 167 million with a 3% EBITA margin.

IMCD: Initiation of Coverage- Is The Strong Organic Growth in Americas Region Here To Stay?

By Baptista Research

  • IMCD N.V., a leading distributor in the specialty chemicals and food ingredients sectors, delivered a mixed but largely positive financial performance in the first quarter of 2025, despite ongoing global economic uncertainties.
  • With Marcus Jordan stepping up as CEO following Valerie Diele-Braun’s resignation for personal reasons, the leadership transition marks a critical juncture for the company.
  • The company’s financial results indicate solid growth marked by a 10% increase in gross profit to EUR 325 million and a 12% rise in EBITA to EUR 142 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars